Skip to main content
. 2021 Jul 27;9(7):e27110. doi: 10.2196/27110

Table 1.

Demographic and symptom characteristics in the data sets defined by the presence or absence of AL.


Training data set Testing data set

No Yes P valuesa No Yes P values
Presence of anastomotic leakage, n (%) 531 (83) 108 (17)
57 (80) 14 (20)
Age, n (%)

<50 64 (12) 80 (15) .36 58 (11) 37 (7) .06

50-59 196 (37) 207 (39)
271 (51) 112 (21)

60-69 218 (41) 191 (36)
170 (32) 303 (57)

>=70 53 (10) 53 (10)
37 (7) 74 (14)
Gender, n (%)

Male 419 (79) 451 (85) .17 409 (77) 377 (71) .66

Female 112 (21) 80 (15)
122 (23) 154 (29)
BMI, n (%)

15-19 27 (5) 48 (9) .74 37 (7) 37 (7) .73

20-25 340 (64) 287 (54)
372 (70) 340 (64)

>=26 165 (31) 196 (37)
122 (23) 154 (29)
Ever smoked, n (%)

No 207 (39) 191 (36) .53 234 (44) 228 (43) .95

Yes 324 (61) 340 (64)
297 (56) 303 (57)
Ever alcohol heavy drinker, n (%)

No 212 (40) 159 (30) .04 250 (47) 303 (57) .52

Yes 319 (60) 372 (70)
281 (53) 228 (43)
Presence of aortic calcification, n (%)

No 419 (79) 292 (55) <.001 457 (86) 303 (57) .01

Yes 112 (21) 239 (45)
74 (14) 228 (43)
Presence of celiac trunk calcification, n (%)

No 473 (89) 366 (69) <.001 457 (86) 457 (86) .98

Yes 58 (11) 165 (31)
74 (14) 74 (14)
FEV1% category, n (%)

30-59 21 (4) 27 (5) .13 37 (7) 74 (14) <.001

60-79 122 (23) 165 (31)
101 (19) 377 (71)

80-130 388 (73) 340 (64)
393 (74) 74 (14)
Abdominal surgery, n (%)

No 473 (89) 446 (84) .18 446 (84) 494 (93) .41

Yes 58 (11) 85 (16)
85 (16) 37 (7)
Presence of cardiac arrhythmia, n (%)

No 462 (87) 441 (83) .31 457 (86) 457 (86) .98

Yes 69 (13) 90 (17)
74 (14) 74 (14)
Presence of peripheral vascular disease, n (%)

No 515 (97) 473 (89) <.001 531 (100) 531 (100)

Yes 16 (3) 58 (11)
0 (0) 0 (0)
Presence of hypertension, n (%)


No 409 (77) 340 (64) <.001 398 (75) 377 (71) .76

Yes 122 (23) 191 (36)
133 (25) 154 (29)
Ever used hypotension drug, n (%)

No 457 (86) 425 (80) .10 457 (86) 419 (79) .50

Yes 74 (14) 106 (20)
74 (14) 112 (21)
Ever taken insulin, n (%)

No 504 (95) 489 (92) .13 510 (96) 457 (86) .12

Yes 27 (5) 42 (8)
21 (4) 74 (14)
Lesion length category, n (%)

1-3 117 (22) 74 (14) .06 96 (18) 154 (29) .25

4-5 218 (41) 234 (44)
297 (56) 303 (57)

6-10 181 (34) 202 (38)
138 (26) 74 (14)

>10 16 (3) 27 (5)
0 (0) 0 (0)
Position of lesion, n (%)

Upper esophagus 175 (33) 149 (28) .90 186 (35) 303 (57) .05

Middle esophagus 212 (40) 234 (44)
186 (35) 191 (36)

Lower esophagus 69 (13) 96 (18)
74 (14) 37 (7)

Upper-middle esophagus 37 (7) 16 (3)
37 (7) 0 (0)

Lower-middle esophagus 27 (5) 37 (7)
27 (5) 0 (0)

Multi-position 16 (3) 5 (1)
21 (4) 0 (0)
ASAb physical status classification, n (%)

1 117 (22) 80 (15) <.001 122 (23) 37 (7) .04

2 372 (70) 356 (67)
398 (75) 419 (79)

3 42 (8) 101 (19)
11 (2) 74 (14)
Blood transfusion, n (%)

No 127 (24) 96 (18) .97 196 (37) 154 (29) .14

Yes 404 (76) 435 (82)
335 (63) 377 (71)
Type of anastomotic, n (%)

No 425 (80) 430 (81) .79 435 (82) 340 (64) .19

Yes 106 (20) 101 (19)
96 (18) 191 (36)
Tube stomach, n (%)

No 181 (34) 170 (32) .07 101 (19) 191 (36) .65

Yes 350 (66) 361 (68)
430 (81) 340 (64)
Surgical approach, n (%)

Nonthoraco-laparoscopy 181 (34) 133 (25) .16 186 (35) 154 (29) .68

Thoraco-laparoscopy 350 (66) 398 (75)
345 (65) 377 (71)
Laparoscope, n (%)


No 202 (38) 165 (31) .03 234 (44) 266 (50) .77

Yes 329 (62) 366 (69)
297 (56) 266 (50)
Histology grade, n (%)

0 276 (52) 218 (41) .80 281 (53) 303 (57) .95

1 255 (48) 313 (59)
250 (47) 228 (43)
T classification, n (%)

0 42 (8) 27 (5) .14 37 (7) 37 (7) .31

1 53 (10) 58 (11)
48 (9) 74 (14)

2 281 (53) 303 (57)
281 (53) 228 (43)

3 159 (30) 143 (27)
170 (32) 191 (36)
Multiple primary, n (%)

No 499 (94) 478 (90) .37 494 (93) 531 (100) .36

Yes 32 (6) 53 (10)
37 (7) 0 (0)
N classification, n (%)

1 133 (25) 122 (23) .26 175 (33) 154 (29) .62

2 101 (19) 101 (19)
64 (12) 37 (7)

3 239 (45) 234 (44)
212 (40) 191 (36)

4 32 (6) 42 (8)
58 (11) 112 (21)

5 27 (5) 32 (6)
21 (4) 37 (7)
Thyroglobulin level, n (%)

<1.7 441 (83) 473 (89) .15 473 (89) 457 (86) .70

>=1.7 90 (17) 58 (11)
58 (11) 74 (14)
Tumor vascular permeability, n (%)

<20 372 (70) 372 (70) .92 324 (61) 419 (79) .23

>=20 159 (30) 159 (30)
207 (39) 112 (21)
Postoperative ventilator-assisted breathing, n (%)


No 515 (97) 473 (89) <.001 520 (98) 457 (86) .04

Yes 16 (3) 58 (11)
11 (2) 74 (14)
Lung infection, n (%)

No 510 (96) 478 (90) <.001 494 (93) 494 (93) 0.99

Yes 21 (4) 53 (10)
37 (7) 37 (7)
Pleural effusion or empyema, n (%)


No 515 (97) 446 (84) <.001 520 (98) 419 (79) <.001

Yes 16 (3) 85 (16)
11 (2) 112 (21)
Incision fat liquefaction and infection, n (%)

No 494 (93) 398 (75) <.001 467 (88) 494 (93) .59

Yes 37 (7) 133 (25)
64 (12) 37 (7)
Hospital Length of Stay, mean (SD) 13.08 (7.2) 35.56 (23.2) <.001 12.75 (4.13) 29.36 (16.72) <.001

aP values are reported using the Pearson chi-square method.

bThe American Society of Anesthesiologists Physical Status Classification System is a well-established assignment that assesses and communicates a patient’s pre-anesthesia medical comorbidities.